ADVISORY, Nov. 15, 2011 (GLOBE NEWSWIRE) -- What: MAP Pharmaceuticals, Inc. (MAPP), a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology, will visit the NASDAQ MarketSite in New York City’s Times Square. In honor of the occasion, Timothy Nelson, President and Chief Executive Officer of MAP Pharmaceuticals will officially ring The NASDAQ Stock Market Opening Bell.
